Clinical trials
Phase 3 Urinary Bladder, Overactive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
89 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 4 |
| 2004 | 8 |
| 2005 | 1 |
| 2006 | 6 |
| 2007 | 7 |
| 2008 | 9 |
| 2009 | 7 |
| 2010 | 4 |
| 2012 | 4 |
| 2013 | 6 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 8 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 70 |
| Terminated | 9 |
| Unknown status | 5 |
| Not yet recruiting | 3 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Pharma Inc | 14 |
| Allergan | 8 |
| Pfizer | 7 |
| Astellas Pharma Europe B.V. | 4 |
| Urovant Sciences GmbH | 4 |
| APOGEPHA Arzneimittel GmbH | 2 |
| Astellas Pharma Europe Ltd. | 2 |
| CHU de Quebec-Universite Laval | 2 |
| Duramed Research | 2 |
| GlaxoSmithKline | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder, Overactive | 89 |
| Urinary Incontinence | 31 |
| Urinary Incontinence, Urge | 17 |
| Urologic Diseases | 5 |
| Nocturia | 4 |
| Lower Urinary Tract Symptoms | 3 |
| Prostatic Hyperplasia | 2 |
| Urinary Bladder Diseases | 2 |
| Diurnal Enuresis | 1 |
| Hematuria | 1 |
Trials
Showing 51 to 75 of 89. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.